Mai-Britt ZoccaCEO at IO Biotech
Mai-Britt Zocca is Chief Executive Officer (CEO) of IO Biotech. She has participated in founding and co-founding of several biotech spinouts. She is a member of the BoD of VAR2 Pharmaceuticals and has held several executive positions in the industry. Mrs. Zocca holds a PhD in tumor immunology and a Master Sc. in Biochemistry. She received her PhD from the Institute of Medical Microbiology and Immunology, University of Copenhagen, and the NIH, National Cancer Institute (NCI), Bethesda, Maryland, USA. Mai-Britt Zocca has more than 15 years of experience in translational immunology (Immuno Oncology) and has published more than 25 articles in peer reviewed international journals. Furthermore, she is an inventor of several patents. Mai-Britt Zocca has focused her work on translational immunology especially for the development of immunotherapies for cancer diseases. Mai-Britt Zocca has been involved in several clinical studies and is also focused on biomarker discovery within the field of immunotherapy and participates in a taskforce consisting of several EU and US clinical departments and the FDA.